A Case Report of Tranexamic Acid for the Treatment of Chronic Subdural Hematoma in an 86-Year-Old Patient

被引:0
作者
Gharaibeh, Shatha [1 ,2 ]
Shurman, Abdallah [1 ,2 ]
Gharaibeh, Abeer [2 ,3 ]
Torcuator, Roy [4 ,5 ]
机构
[1] Univ Michigan Flint, Ctr Cognit & Neuroeth, Flint, MI 48502 USA
[2] Insight Res Inst, Clin Res, Flint, MI 48507 USA
[3] Insight Inst Neurosurg & Neurosci, Clin Res, Flint, MI USA
[4] Insight Inst Neurosurg & Neurosci, Neurosurg, Flint, MI USA
[5] Insight Surg Hosp, Neurosurg, Warren, MI USA
关键词
txa; surgery-preventing strategies; csdh; chronic subdural hematoma; tranexamic acid; BURR-HOLE EVACUATION;
D O I
10.7759/cureus.66846
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fibrinolytic and coagulative hyperactivity is proven to have a role in liquefaction and progression of chronic subdural hematoma (CSDH). Tranexamic acid was one of the pharmaceutical options that was explored, as it inhibits the hyper-fibrinolytic activity and reduces the vascular permeability in CSDH, leading to a gradual resolution of the hematoma. In this case study, we present a case of using tranexamic acid for CSDH treatment in an 86-year-old patient with co-morbidities. The complete resolution of the hematoma following using tranexamic acid in this case with no history of recurrence in two years follow-up supports its efficacy in CSDH treatment and may be considered as one of the strategies that help prevent surgeries.
引用
收藏
页数:5
相关论文
共 28 条
[1]   Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations [J].
Balser, David ;
Farooq, Sameer ;
Mehmood, Talha ;
Reyes, Marleen ;
Samadani, Uzma .
JOURNAL OF NEUROSURGERY, 2015, 123 (05) :1209-1215
[2]   The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients [J].
Cai, Johnny ;
Ribkoff, Jessica ;
Olson, Sven ;
Raghunathan, Vikram ;
Al-Samkari, Hanny ;
DeLoughery, Thomas G. ;
Shatzel, Joseph J. .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (02) :79-87
[3]  
Chauncey JM, 2024, Tranexamic Acid
[4]   Effect of postoperative tranexamic acid on recurrence rate and complications in chronic subdural hematomas patients: preliminary results of a randomized controlled clinical trial [J].
de Paula, Marcus Vinicius Carneiro Torres ;
Ribeiro, Bernardo Duarte Chamon ;
Melo, Marina Mendes ;
de Freitas, Pedro Victor Vidal ;
Pahl, Felix Hendrik ;
de Oliveira, Matheus Fernandes ;
Rotta, Jose Marcus .
NEUROSURGICAL REVIEW, 2023, 46 (01)
[5]   Tranexamic acid - A review of its use in surgery and other indications [J].
Dunn, CJ ;
Goa, KL .
DRUGS, 1999, 57 (06) :1005-1032
[6]   Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy [J].
Edlmann, Ellie ;
Giorgi-Coll, Susan ;
Whitfield, Peter C. ;
Carpenter, Keri L. H. ;
Hutchinson, Peter J. .
JOURNAL OF NEUROINFLAMMATION, 2017, 14
[7]   Updates in Chronic Subdural Hematoma: Epidemiology, Etiology, Pathogenesis, Treatment, and Outcome [J].
Feghali, James ;
Yang, Wuyang ;
Huang, Judy .
WORLD NEUROSURGERY, 2020, 141 :339-345
[8]   Pathophysiology and Nonsurgical Treatment of Chronic Subdural Hematoma: From Past to Present to Future [J].
Holl, Dana C. ;
Volovici, Victor ;
Dirven, Clemens M. F. ;
Peul, Wilco C. ;
van Kooten, Fop ;
Jellema, Korne ;
van der Gaag, Niels A. ;
Miah, Ishita P. ;
Kho, Kuan H. ;
den Hertog, Heleen M. ;
Lingsma, Hester F. ;
Dammers, Ruben .
WORLD NEUROSURGERY, 2018, 116 :402-+
[9]   Tranexamic acid to prevent operation in chronic subdural haematoma (TORCH): study protocol for a randomised placebo-controlled clinical trial [J].
Immenga, S. ;
Lodewijkx, R. ;
Roos, Y. B. W. E. M. ;
Middeldorp, S. ;
Majoie, C. B. L. M. ;
Willems, H. C. ;
Vandertop, W. P. ;
Verbaan, D. .
TRIALS, 2022, 23 (01)
[10]   Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial [J].
Iorio-Morin, Christian ;
Blanchard, Jocelyn ;
Richer, Maxime ;
Mathieu, David .
TRIALS, 2016, 17